-positive advanced breast cancer. Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023... blood test cleared by the U.S. Food & Drug Administration (FDA) for detecting and counting CTCs in metastatic breast...
. You will be responsible for raising awareness of clinical research and trials amongst secondary breast cancer patients and their families...We are seeking a registered nurse with a keen interest in clinical trials for the opportunity to work with the Cancer...
and selling the Novartis Breast Cancer product covering the Thames Valley area. We are open to different levels of experience... Ideally specialist knowledge from Breast Cancer ideally An existing network of contacts and relationships from the...
Oncology experience, ideally Breast Cancer, Lung Cancer, Gastro-intestinal Cancer, Neuroendocrine Cancer; Prostate Cancer...
and international phase III multicentre randomised controlled trials, and phase II trials of targeted treatments with a focus on breast..., urological and head and neck cancer treatments. This post offers an excellent opportunity...
jaw, for example patients having IV infusions of bisphosphonates following breast cancer. b. Supporting the dental... assessment of patients prior to the management of head and neck cancer. c. Support for patients requiring acute endodontic...
for a priority Breast Cancer brand. Job Description Location: This is is a field based role covering Scotland, Northern Ireland...
and selling the Novartis Breast Cancer product across North London to Bedford and Luton. We are open to different levels... in our breast cancer therapy area. Job Description Location: This position will cover the territory North London...
the team include; Oncology – breast cancer (Phase III), Global, 6000 subjects Oncology – rare cancers in paediatric...
opportunity for PhD study in the world-leading Cancer Research UK Cambridge Institute (CRUK CI), to start a research career in... an environment committed to training outstanding cancer research scientists of the future. The Institute's particular strengths...